Tezepelumab in severe asthma: chest computed tomography assessment of airway remodeling and clinical remission

Key Points

• Improving lung function indicates that tezepelumab significantly benefits severe asthma symptoms, leading to better quality of life.
• Radiological outcomes revealed notable airway remodeling improvements post-treatment, suggesting effective pathology management.
• Assessment included chest computed tomography imaging to evaluate structural changes in the lungs due to treatment.
• Findings highlight the potential for achieving clinical remission in severe asthma patients with tezepelumab, though larger trials are warranted.

Abstract